By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare company Clarient and Acorn Research today announced a collaboration targeting the molecular testing of tumor samples.

The collaboration, the terms of which were not disclosed, brings together Clarient's expertise in cancer diagnostics and Acorn's oncology network and advanced bioinformatics platform, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.